Meda E. Pavkov

22.4k citations
117 papers · 11.8k · 6 hit papers · h-index 35

Impact in

  • Nephrology top 0.2%
    • Chronic Kidney Disease and Diabetes
    • Dialysis and Renal Disease Management
    • Diabetes Treatment and Management
    • Diabetes Management and Research
    • Diabetes, Cardiovascular Risks, and Lipoproteins
    • Natural Antidiabetic Agents Studies

Papers in

    • Chronic Kidney Disease and Diabetes 41
    • Acute Kidney Injury Research 6
    • Dialysis and Renal Disease Management 5
    • Diabetes Treatment and Management 13
    • Diabetes, Cardiovascular Risks, and Lipoproteins 11
    • Diabetes Management and Research 7

Meda E. Pavkov

105 papers receiving 11.6k citations

Meda E. Pavkov's Hit Papers

Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021 2022 · 179 citations
1790+3+6Years since publication2.0k4.0k6.0k

Peers

Meda E. Pavkov
Comparison fields: 5 of 174
  • Nephrology 1.7k
  • Endocrinology, Diabetes and Metabolism 3.2k
  • Rehabilitation 279
  • Clinical Biochemistry 264
  • Physiology 911
Replace Dianna J. Magliano with:
Dianna J. Magliano Australia
Jean Claude Mbanya Cameroon
Linda S. Geiss United States
Janet B. McGill United States
Pouya Saeedi Belgium
João Diogo da Rocha Fernandes Denmark
Abdul Basit Pakistan
Belma Malanda Belgium
Helen M. Colhoun United Kingdom
Ayesha A. Motala South Africa
Meda E. Pavkov relative to Dianna J. Magliano Australia Dianna J. Magliano's profile →
Citations per field
00.5×1.5×2.3×
Dianna J. Magliano · 1×
Citations per year

Countries citing papers authored by Meda E. Pavkov

Since Specialization
Citations

This map shows the geographic impact of Meda E. Pavkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meda E. Pavkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meda E. Pavkov more than expected).

Fields of papers citing papers by Meda E. Pavkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meda E. Pavkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meda E. Pavkov. The network helps show where Meda E. Pavkov may publish in the future.

Co-authors

The 25 scholars most cited alongside Meda E. Pavkov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Meda E. Pavkov Line = papers co-authored together Meda E. Pavkov links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.

#Work
1
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
Hit paper breakdown →
20216193
2
Global trends in diabetes complications: a review of current evidence
Hit paper breakdown →
20181119
3
The Global Epidemiology of Diabetes and Kidney Disease
Hit paper breakdown →
2018475
4
Trends in Prevalence of Chronic Kidney Disease in the United States
Hit paper breakdown →
2016437
5 2010297
6
Trends in incidence of total or type 2 diabetes: systematic review
Hit paper breakdown →
2019257
7 2006231
8 2014215
9
Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021
Hit paper breakdown →
2022179
10 2012160
11 2010105
12 2007100
13 201495
14 201883
15 201072
16 202268
17 201167
18 201867
19 201557
20 202255

About Meda E. Pavkov

Meda E. Pavkov is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Genetics, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health, having authored 117 papers that have together received 11.8k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (41 papers), Diabetes Treatment and Management (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Diabetes and associated disorders (10 papers), Diabetes Management and Research (7 papers), Acute Kidney Injury Research (6 papers), Dialysis and Renal Disease Management (5 papers) and Cardiovascular Health and Risk Factors (5 papers). The work is most often cited by research in Nephrology (1.7k citations), Endocrinology, Diabetes and Metabolism (3.2k citations), Rehabilitation (279 citations), Clinical Biochemistry (264 citations) and Physiology (911 citations). Meda E. Pavkov has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Dianna J. Magliano, Jessica L. Harding, Sarah H. Wild, Steven James, Hong Sun, Edward J. Boyko, William H. Herman, Christian Bommer, Suvi Karuranga and Juliana C.N. Chan. Their work appears in journals such as Diabetes Care, American Journal of Kidney Diseases, Clinical Journal of the American Society of Nephrology, Diabetes and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact